Prostate cancer: to screen or not to screen?
- PMID: 20152514
- DOI: 10.1016/j.ucl.2009.11.004
Prostate cancer: to screen or not to screen?
Abstract
The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and financial costs. Efforts to improve screening with better markers and more selective treatment may make population-based screening more effective.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources